FDA-approved Symbol - Search News

FDA approves 1st rapid-acting insulin

FDA approves first rapid-acting insulin

According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in people with diabetes.

Daily Journal · 6h

FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes

Merilog is the third insulin biosimilar product approved by the FDA and joins the two long-acting insulin biosimilar products approved in 2021 by the FDA. Approval of biosimilar products can increase patient access to safe and effective treatment options.

Business Insider · 5h

FDA approves Sanofi biosimilar product for treatment of diabetes

The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric

Seeking Alpha on MSN · 4h

Sanofi gets FDA approval for NovoLog insulin biosimilar

Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children with diabetes mellitus.

FDA approves subcutaneous Merilog for glycemic control in diabetes

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

SMA11h

FDA approves new tablet version of oral SMA treatment Evrysdi

The U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of Evrysdi (risdiplam), an approved oral ...

8d

Supernus: New Approval Holds Promise Of Increased Growth

Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...

FDA approves Evrysdi tablets for spinal muscular atrophy

The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results